4.7 Letter

New Onset of Inflammatory Bowel Disease in Three Patients Undergoing IL-17A Inhibitor Secukinumab: A Case Series

Journal

AMERICAN JOURNAL OF GASTROENTEROLOGY
Volume 114, Issue 1, Pages 179-180

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1038/s41395-018-0422-z

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available